Robert Hofmeister

Insider Reports History

Entity
Individual
Location
C/O Tcr2 Therapeutics Inc., 100 Binney Street, Cambridge, MA
Signature
/s/ Melinda Lackey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Hofmeister:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Scientific Officer Common Stock 45.9K $78.9K $1.72 Dec 9, 2021 Direct
TCR2 THERAPEUTICS INC. Chief Scientific Officer Stock Option (Right to Buy) 100K $74K $0.74 Dec 9, 2021 Direct
Alaunos Therapeutics, Inc. Director Employee Stock Option (right to buy) 12.8K Jun 6, 2024 Direct

Insider Reports Filed by Robert Hofmeister

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRT Alaunos Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
TCRT Alaunos Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
TCRT Alaunos Therapeutics, Inc. Mar 30, 2023 2 $0 4 Apr 19, 2023 Director
TCRT Alaunos Therapeutics, Inc. Mar 30, 2023 0 $0 3 Apr 19, 2023 Director
TCRR TCR2 THERAPEUTICS INC. Dec 9, 2021 1 $0 4 Dec 10, 2021 Chief Scientific Officer